Related Experiment Videos
Aging, dementia and calcium metabolism
1Psychiatrische Klinik und Poliklinik, Universitätsklinikum Rudolf Virchow, Berlin, Federal Republic of Germany.
Journal of Neural Transmission. Supplementum
|December 16, 1998
Summary
Nimodipine shows promise in treating vascular and Alzheimer's dementia by addressing disturbed neuronal calcium metabolism. Clinical studies indicate its potential therapeutic benefits for these cognitive conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Neuronal calcium metabolism is crucial for brain function.
- Disturbances in calcium signaling are implicated in dementia pathogenesis.
- Vascular dementia and Alzheimer's dementia represent significant neurological challenges.
Purpose of the Study:
- To review clinical findings on nimodipine's efficacy.
- To explore nimodipine's role in managing dementia.
- To connect nimodipine's mechanism to calcium metabolism theory.
Main Methods:
- Literature review of clinical studies.
- Analysis of nimodipine's effects in dementia patients.
- Theoretical discussion of calcium metabolism.
Main Results:
- Nimodipine demonstrated potential in clinical trials for dementia.
- Evidence suggests nimodipine may modulate neuronal calcium levels.
- The drug's utility in vascular and Alzheimer's dementia was assessed.
Conclusions:
- Nimodipine warrants further investigation for dementia treatment.
- Targeting neuronal calcium metabolism is a viable therapeutic strategy.
- Clinical results support nimodipine's role in managing specific dementias.